Abstract

Genome-wide association studies of gastric cancer (GC) cases have revealed common gastric cancer susceptibility loci with low effect size. We investigated rare variants with high effect size via whole-exome sequencing (WES) of subjects with familial clustering of gastric cancer. WES of DNAs from the blood of 19 gastric cancer patients and 36 unaffected family members from 14 families with two or more gastric cancer patients were tested. Linkage analysis combined with association tests were performed using Pedigree Variant Annotation, Analysis, and Search Tool (pVAAST) software. Based on the logarithm of odds (LOD) and permutation-based composite likelihood ratio test (CLRT) from pVAAST, MUC4 was identified as a predisposing gene (LOD P-value = 1.9×10-5; permutation-based P-value of CLRT ≤ 9.9×10-9). In a larger cohort consisting of 597 GC patients and 9,759 healthy controls genotyped with SNP array, we discovered common variants in MUC4 regions (rs148735556, rs11717039, and rs547775645) significantly associated with GC supporting the association of MUC4 with gastric cancer. And the MUC4 variants were found in higher frequency in The Cancer Genome Atlas Study (TCGA) germline samples of patients with multiple cancer types. Immunohistochemistry indicated that MUC4 was downregulated in the noncancerous gastric mucosa of subjects with MUC4 germline missense variants, suggesting that loss of the protective function of MUC4 predisposes an individual to gastric cancer. Rare variants in MUC4 can be novel gastric cancer susceptibility loci in Koreans possessing the familial clustering of gastric cancer.

Highlights

  • Gastric cancer (GC) is one of the most common cancers and is the third leading cause of cancer mortality worldwide, with an estimated 783,000 deaths in 2018 [1]

  • The objective of this study was to identify GC-associated germline variants with a high effect size [19] by linkage and association analyses based on whole-exome sequencing (WES) of subjects with familial clustering of GC not limited to hereditary diffuse gastric cancer (HDGC)

  • A higher percentage of males tended to be present in the GC group than in the other group (63.2% vs. 33.3%, p = 0.034)

Read more

Summary

Introduction

Gastric cancer (GC) is one of the most common cancers and is the third leading cause of cancer mortality worldwide, with an estimated 783,000 deaths in 2018 [1]. South Korea has the highest incidence of stomach cancer in the world [1]. A positive family history is a well-known risk factor for GC, in addition to male sex, Helicobacter pylori infection, smoking, and frequent consumption of salty food and dietary nitrite [2]. Most GC cases are sporadic, with approximately 90% developing in communities carrying only an average risk [3, 4]. Hereditary cancer syndromes including hereditary diffuse gastric cancer (HDGC) account for less than 3% of all GC cases [5]. The remaining 7% is found in individuals with a positive family history but without a diagnosed inherited cancer syndrome [5]

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.